INNATEvertnoir.png
Innate Pharma Virtual 2021 Annual General Meeting
12 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, May 12, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) has published the convening notice to the...
INNATEvertnoir.png
Innate Pharma : Assemblée Générale 2021 a Distance
12 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, 12 mai 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a publié aujourd’hui au Bulletin des...
INNATEvertnoir.png
Innate Pharma Virtual 2021 Annual General Meeting
12 mai 2021 01h00 HE | INNATE PHARMA
MARSEILLE, France, May 12, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) has published the convening notice to the...
INNATEvertnoir.png
Innate Pharma First Quarter 2021 Report
11 mai 2021 01h00 HE | INNATE PHARMA
Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signalCompany’s first NK cell engager selected by Sanofi as drug candidate...
INNATEvertnoir.png
Innate Pharma First Quarter 2021 Report
11 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, May 11, 2021 (GLOBE NEWSWIRE) -- Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal Company’s...
INNATEvertnoir.png
Information Financiere du Premier Trimestre 2021
11 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, 11 mai 2021 (GLOBE NEWSWIRE) -- Progression de l’essai TELLOMAK : lacutamab a démontré un signal préliminaire positif permettant à la cohorte de patients présentant un mycosis...
INNATEvertnoir.png
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
04 mai 2021 01h00 HE | INNATE PHARMA
MARSEILLE, France, May 04, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold...
INNATEvertnoir.png
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
04 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, May 04, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold...
INNATEvertnoir.png
Innate Pharma Organise une Conférence Téléphonique et un Webcast pour son Information Financière du Premier Trimestre 2021
04 mai 2021 01h00 HE | INNATE PHARMA
Marseille, France, 04 mai 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle...
INNATEvertnoir.png
Innate Pharma Files its 2020 Universal Registration Document (Document d'Enregistrement Universel) and 2020 Annual Report on Form 20-F
28 avr. 2021 01h00 HE | INNATE PHARMA
Marseille, France, April 28, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2020...